ArticleMedicina (Kaunas, Lithuania)2022

A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma.

Hana Studentova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.